DuPont Sells Kevlar and Nomex Aramids Business to Arclin for $1.8 Billion
DuPont has sold its Aramids business, including Kevlar and Nomex brands, to Arclin for $1.8 billion. The divestiture shifts DuPont’s focus to healthcare, water, construction and industrial markets while bolstering its cash position for strategic investments or debt reduction.
1. Divestiture Details
On April 1, 2026, DuPont completed the sale of its Aramids business to Arclin for $1.8 billion. The transaction transfers ownership of the Kevlar and Nomex brands along with associated manufacturing operations and roughly 1,800 employees to Arclin.
2. Strategic Refocus
Following the sale, DuPont realigns its portfolio around its core markets in healthcare, water, construction and industrial applications. Exiting the Aramids segment allows the company to concentrate resources and innovation on higher-growth areas.
3. Financial Implications
Proceeds from the divestiture enhance DuPont’s liquidity and provide flexibility for debt repayment, share repurchases or targeted acquisitions. Management has indicated that strengthening the balance sheet and funding strategic initiatives are top priorities.